Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Stress and hormones like progesterone can affect absence seizures, but their effects change with different life stages.

Young Czech women with PCOS have a higher risk of heart problems and should be regularly checked for cholesterol and glucose issues.

Hirsutism and alopecia during menopause can be diagnosed and treated with specific hormonal and topical therapies.

Androgen replacement therapy can improve libido and mood in women with severe androgen deficiency, but more research is needed on its long-term safety.

Testosterone therapy can help improve mood, sexual function, and bone health in women with low androgen levels, but more research is needed to establish safe and effective guidelines.

The document concludes that PCOS is a complex disorder caused by both genetic and environmental factors, affecting women's health in various ways, and requires personalized treatment.

Women with PCOS should be screened for heart disease risk and manage their health to prevent it.

The document likely offers guidance on treating a woman's excessive hair growth, considering her symptoms and obesity.

Higher levels of unbound testosterone are linked to increased insulin resistance, especially in women with polycystic ovary syndrome.

Hirsutism is more linked to high androgen levels than acne or hair loss, and a mix of hormonal tests is best for diagnosis; certain treatments can reduce symptoms.

New treatments for male hypogonadism are effective and should be personalized.

Acne is caused by genetics, diet, hormones, and bacteria, with treatments not yet curative.

Liraglutide caused significant weight loss in some obese women with PCOS, especially those with severe obesity and insulin resistance.

Menopause and aging can affect women's quality of life and sexuality, but hormone therapies may help alleviate these issues.

Certain microRNAs in the fluid around eggs are linked to Polycystic Ovary Syndrome and may help diagnose it.

Insulin resistance is significantly linked to a higher risk of depression in women with PCOS.

Women with PCOS are more likely to have insulin resistance and obesity, especially those with the most severe type I PCOS.

Metformin and rosiglitazone both improved insulin use and hormonal symptoms in women with PCOS.

Weight loss and metformin don't significantly change vaspin levels in women with PCOS.

Finasteride and flutamide effectively reduce hirsutism in PCOS women, with flutamide also lowering hormone levels.

Cyproterone acetate treatment is safe and causes mild feminization, which increases with added estrogen.

Epilepsy and certain epilepsy drugs can lead to reproductive problems in women, but changing medication might improve these issues.

Women with severe types of PCOS are more likely to have metabolic syndrome, and belly fat is a key predictor of this risk.

The study suggests that being overweight or obese, not PCOS itself, is strongly linked to insulin resistance.

Testosterone therapy can improve sexual desire and function in postmenopausal women but should be used cautiously and not based solely on testosterone levels.

Spironolactone may effectively treat female hair loss, especially with hyperandrogenism signs.

Benign Prostatic Hyperplasia may be caused by changes in how the body processes male hormones.

Cross-sex hormone therapy is important for managing gender dysphoria and requires careful monitoring and healthcare provider education.

Lower lipin 1β in belly fat is linked to insulin resistance in people with polycystic ovary syndrome.

Isotretinoin improves severe acne without changing androgen or insulin levels but may increase body weight and triglycerides.